Sentinel Oncology

Accent Therapeutics

This biopharmaceutical company develops small molecule precision therapies for patients with various types of cancer.

Senex Biotechnology

This drug discovery company develops small-molecule inhibitors targeting gene regulation proteins for pharmaceutical partners and healthcare providers treating prostate and breast cancers.

Vanquish Oncology

This drug development company produces small-molecule therapeutics that trigger cancer cell death for patients with unmet or underserved oncological needs.

KyDo Therapeutics

This company develops covalent-allosteric small molecule inhibitors for the treatment of challenging cancer variants within the oncology sector.

Scenic Biotech

This company develops disease-modifying small molecule therapeutics for patients with rare genetic and neurodegenerative disorders using its proprietary genetic modifier discovery platform.

Akanocure Pharmaceuticals

This company develops small molecule drugs targeting orphan and unmet needs in oncology for healthcare providers and patients.

Scorpion Therapeutics

This clinical-stage company develops small-molecule drugs and targeted therapies for patients with various forms of cancer.

iOnctura

The company develops precision small-molecule medicines to treat patients with neglected and hard-to-treat solid tumours and cancers.